NO962921L - T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling - Google Patents

T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling

Info

Publication number
NO962921L
NO962921L NO962921A NO962921A NO962921L NO 962921 L NO962921 L NO 962921L NO 962921 A NO962921 A NO 962921A NO 962921 A NO962921 A NO 962921A NO 962921 L NO962921 L NO 962921L
Authority
NO
Norway
Prior art keywords
antigen receptor
cell antigen
proteins
preparation
region
Prior art date
Application number
NO962921A
Other languages
English (en)
Norwegian (no)
Other versions
NO962921D0 (no
Inventor
Savvas C Makrides
Patrick C Kung
Original Assignee
T Cell Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc filed Critical T Cell Sciences Inc
Publication of NO962921D0 publication Critical patent/NO962921D0/no
Publication of NO962921L publication Critical patent/NO962921L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
NO962921A 1994-01-13 1996-07-11 T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling NO962921L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/181,492 US5552300A (en) 1994-01-13 1994-01-13 T cell antigen receptor V region proteins and methods of preparation thereof
PCT/US1995/000408 WO1995019435A2 (fr) 1994-01-13 1995-01-12 Proteines de la region v du recepteur d'antigene des lymphocytes t et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
NO962921D0 NO962921D0 (no) 1996-07-11
NO962921L true NO962921L (no) 1996-09-02

Family

ID=22664497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962921A NO962921L (no) 1994-01-13 1996-07-11 T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling

Country Status (21)

Country Link
US (1) US5552300A (fr)
EP (1) EP0738322A1 (fr)
JP (1) JPH10501961A (fr)
KR (1) KR100213396B1 (fr)
AU (1) AU700661B2 (fr)
BR (1) BR9506612A (fr)
CA (1) CA2181171A1 (fr)
CZ (1) CZ9602009A3 (fr)
EE (1) EE03287B1 (fr)
FI (1) FI962844L (fr)
HU (1) HUT75551A (fr)
IL (1) IL112316A0 (fr)
LV (1) LV11630B (fr)
MX (1) MX9602750A (fr)
NO (1) NO962921L (fr)
NZ (2) NZ279605A (fr)
PL (1) PL181072B1 (fr)
SG (1) SG52342A1 (fr)
SK (1) SK90696A3 (fr)
WO (1) WO1995019435A2 (fr)
ZA (1) ZA95261B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113903A (en) * 1989-03-21 2000-09-05 The Immune Response Corporation Peptides and methods against diabetes
US20040229282A1 (en) * 1997-03-10 2004-11-18 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en) * 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20030109680A1 (en) * 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US7749498B2 (en) * 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) * 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
AU4188100A (en) 1999-04-08 2000-11-14 Gregory M. Glenn Dry formulation for transcutaneous immunization
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US20030190705A1 (en) * 2001-10-29 2003-10-09 Sunol Molecular Corporation Method of humanizing immune system molecules
WO2004015070A2 (fr) 2002-08-08 2004-02-19 Baylor College Of Medicine Isolation et identification de cellules t
CA2530980A1 (fr) * 2003-06-19 2005-01-20 Tanox, Inc. Anticorps specifiques du facteur tissulaire pour prevenir ou traiter unelesion pulmonaire aigue ou un syndrome de detresse respiratoire aigue
CA2572870A1 (fr) * 2004-07-06 2006-01-12 Transpharma Medical Ltd. Systeme d'administration pour immunisation transdermique
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
US20070009542A1 (en) * 2005-07-05 2007-01-11 Galit Levin Method and device for transdermal immunization
EP2258441A3 (fr) 2005-09-02 2011-09-21 Intercell USA, Inc. Dispositifs d administration transcutanée de vaccins et d'administration transdermique de médicaments
PT2016414E (pt) * 2006-05-05 2015-11-24 Opexa Therapeutics Vacina de células t
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
CN102573883A (zh) 2009-06-12 2012-07-11 疫苗技术公司 用于促进细胞-介导的免疫应答的方法和组合物
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2011059836A2 (fr) 2009-10-29 2011-05-19 Trustees Of Dartmouth College Compositions de lymphocytes t déficientes en récepteurs de lymphocytes t
WO2013033626A2 (fr) 2011-08-31 2013-03-07 Trustees Of Dartmouth College Produits thérapeutiques ciblant un récepteur nkp30
WO2013169691A1 (fr) 2012-05-07 2013-11-14 Trustees Of Dartmouth College Anticorps anti-b7-h6, protéines de fusion, et leurs procédés d'utilisation
WO2014044690A1 (fr) 2012-09-18 2014-03-27 Valneva Austria Gmbh Vaccins améliorés

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713332A (en) * 1984-01-13 1987-12-15 The Ontario Cancer Institute T cell specific CDNA clone
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor
EP0570027B1 (fr) * 1984-03-01 1999-12-29 The Board Of Trustees Of The Leland Stanford Junior University Récepteur de cellules-T, spécifiques pour des polypeptides d'antigènes et polynucléotides apparentés
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5024940A (en) * 1987-02-19 1991-06-18 T Cell Sciences, Inc. Nucleic acids encoding the delta chain of the T cell antigen receptor
US5185250A (en) * 1986-07-03 1993-02-09 T Cell Sciences, Inc. Human γ, δT cell antigen receptor polypeptides and nucleic acids
US5260223A (en) * 1986-07-03 1993-11-09 President & Fellows Of Harvard College Methods for detection of human gamma, γ T cell receptor
US5340921A (en) * 1986-07-03 1994-08-23 T Cell Sciences, Inc. Γ, δT cell receptor and methods and detection
EP0712928A2 (fr) * 1987-06-23 1996-05-22 The Board Of Trustees Of The Leland Stanford Junior University Récepteur d'antigène de T-cellules
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
ES2062519T5 (es) * 1989-03-21 2003-07-16 Immune Response Corp Inc Vacunacion y metodos contra enfermedades originadas a partir de respuestas patogenicas mediante poblaciones especificas de linfocitos t.
CA2032138A1 (fr) * 1989-05-02 1990-11-03 Irun R. Cohen Cellules t anti-ergotypiques pour le traitement ou la prevention des maladies anto-immunes et leurs modes d'utilisation
CA2072356A1 (fr) * 1989-12-29 1991-06-30 James L. Urban Diagnostic et traitement des maladies
US5216132A (en) * 1990-01-12 1993-06-01 Protein Design Labs, Inc. Soluble t-cell antigen receptor chimeric antigens
EP0725277A3 (fr) * 1990-05-01 1996-12-04 Univ Leland Stanford Junior Transcrits variables de récepteurs de lymphocytes T utilisés comme marqueurs relatifs à des maladies
DE69124518T2 (de) * 1990-08-09 1997-05-15 National Jewish Center For Immunology And Respiratory Medicine, Denver, Col. Herstellung monoklonaler Antikörper gegen menschliches Vbeta T-Zellrezeptorelement unter Verwendung rekombinanter DNA-Vektoren
WO1992013950A2 (fr) * 1991-02-12 1992-08-20 Roussel-Uclaf SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
ES2144418T3 (es) * 1991-05-31 2000-06-16 Connetics Corp Peptidos de receptores de celulas t como agentes terapeuticos para enfermedades relacionadas con el sistema inmunitario.
WO1993006135A1 (fr) * 1991-09-23 1993-04-01 Genentech, Inc. Diagnostic et therapie de maladies auto-immunitaires
US5333487A (en) * 1991-11-15 1994-08-02 Hughes Aircraft Company Spark-excited fluorescence sensor
US5212091A (en) * 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor

Also Published As

Publication number Publication date
SG52342A1 (en) 1999-06-22
NZ279605A (en) 1999-01-28
BR9506612A (pt) 1997-09-16
PL319374A1 (en) 1997-08-04
WO1995019435A2 (fr) 1995-07-20
LV11630A (lv) 1996-12-20
EP0738322A1 (fr) 1996-10-23
FI962844A7 (fi) 1996-08-29
LV11630B (en) 1997-08-20
CA2181171A1 (fr) 1995-07-20
AU700661B2 (en) 1999-01-14
FI962844L (fi) 1996-08-29
KR970700772A (ko) 1997-02-12
PL181072B1 (pl) 2001-05-31
NZ332715A (en) 2000-06-23
JPH10501961A (ja) 1998-02-24
US5552300A (en) 1996-09-03
CZ9602009A3 (en) 1997-12-17
HU9601908D0 (en) 1996-09-30
NO962921D0 (no) 1996-07-11
IL112316A0 (en) 1995-03-30
HUT75551A (en) 1997-05-28
AU1678495A (en) 1995-08-01
SK90696A3 (en) 1997-07-09
KR100213396B1 (ko) 1999-08-02
EE03287B1 (et) 2000-08-15
WO1995019435A3 (fr) 1995-08-24
MX9602750A (es) 1997-05-31
FI962844A0 (fi) 1996-07-12
ZA95261B (en) 1995-11-14

Similar Documents

Publication Publication Date Title
NO962921L (no) T celle antigenreseptor V regionprotiner og fremgangsmåte for fremstilling
NZ510367A (en) Interleukin 17-like receptor protein nucleic acid sequence encoding the interleukin receptor protein and method of expressing protein in recombinant vector
PH25120A (en) Replicable expression vehicle and process of preparation thereof
ES2009905A6 (es) Procedimiento para la preparacion de anticuerpos frente a virus de sida.
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
EP0338767A3 (fr) Anticorps chimériques et recombinants dirigés contre un antigène du type adénocarcinôme humain
FI893702A7 (fi) Menetelmä ihmisen seerumialbumiinin ja muiden heterologisten proteiinien mikrobiologiseksi valmistamiseksi hiivasta
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
AU3204689A (en) Amyloid protein precursors, genetic probes, antibodies, and methods of use
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
NO180181C (no) Fremgangsmåte for fremstilling av et is-kjernedannende protein, plasmider og bakteriestammer
AU3563397A (en) Methods for determining the presence of brain protein s-100
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
ZA892518B (en) Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
DE69635081D1 (de) Enamel-matrix bezogene polypeptide
FI870501L (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
WO1998056813A3 (fr) Deux proteines de fusion membranaire humaines
WO1999043829A3 (fr) Proteines liees au cycle cellulaire
DK1077720T3 (da) Præparat til induktion af en tumorspecifik immunrespons, fremgangsmåde til fremstilling heraf samt anvendelse af præparatet til behandling af neoplasier
DK266187A (da) Rekombinant humant protein s, fremgangsmaade til fremstilling heraf og rekombinant dna-vektor til brug ved fremgangsmaaden
WO1998049194A3 (fr) Nouvelle proteine de type ras
WO1998050425A3 (fr) Proteine analogue de tsc-22 humaine
WO1999019482A3 (fr) Proteines associees au transport des vesicules
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application